好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Prodromal Markers of Parkinson’s Disease in a Cohort of US Black Women
Movement Disorders
P2 - Poster Session 2 (8:00 AM-9:00 AM)
5-012

To estimate the prevalence of constipation, hyposmia, and REM sleep behavior disorder (RBD), and their association with Parkinson’s disease (PD) in a cohort of US Black women.

Studies conducted in predominantly White populations have shown that constipation, hyposmia, and RBD are major prodromal features of PD, which could help identify the disease at earlier stages. However, whether these features predict PD in other populations, such as Black women, is unknown. 

The BWHS is a prospective cohort of 59,000 US Black women aged 21-69 at enrollment in 1995.  Participants are followed biennially through postal and online questionnaires. Self-reported health conditions, including PD, are validated using physician records and supplemental questionnaires. The 2024 cohort questionnaire contained questions on constipation (bowel movement ≤ every other day, and/or laxative use ≥ weekly), hyposmia (perceived smell problems), and probable RBD (acting out of dreams).  We estimated age-adjusted odds ratios and 95% confidence intervals (CI) to examine the cross-sectional association of these features with PD.

To date, 14,272 women have completed the online questionnaire, including 24 with a previous diagnosis of PD.  Among them 32% reported constipation, 6% reported hyposmia, and 8% reported probable RBD; approximately 5% reported two or more features. All features examined were significantly associated with PD, with the strongest association observed for hyposmia (OR=13.55; 95% CI 6.04-30.38), followed by probable RBD (OR=8.39; 95% CI 3.76-18.75). Having all three features versus none was associated with OR of 179.43 (95% CI 46.67, 689.80).

In this preliminary cross-sectional analysis, constipation, hyposmia, and probable RBD were strongly associated with PD in Black women with magnitudes similar to those previously observed in White women. These features could therefore contribute to detection of prodromal PD in this population. Longitudinal follow-up of this cohort will allow us to validate our findings. 
Authors/Disclosures
Mario H. Flores, MD, PhD (Harvard T.H. Chan School of Public Health)
PRESENTER
Dr. Flores has nothing to disclose.
Yvette Cozier (Boston University School of Public Health) Yvette Cozier has nothing to disclose.
Cordelia Russell, MPH Ms. Russell has nothing to disclose.
Virginia Cafferky, MPH Miss Cafferky has received personal compensation for serving as an employee of Rhode Island Department of Health. Miss Cafferky has stock in CVS.
Albert Hung, MD, PhD (Massachusetts General Hospital) The institution of Dr. Hung has received research support from Parkinson's Foundation. The institution of Dr. Hung has received research support from Rho, Inc..
Michael Schwarzschild, MD, PhD (Massachusetts General Hospital) The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities.
Marianna Cortese, MD, PhD (Harvard T.H. Chan School of Public Health) Dr. Cortese has received personal compensation in the range of $500-$4,999 for serving as a speaker at educational event with Roche.
Kjetil Bjornevik, MD, PhD (Harvard T.H. Chan School of Public Health) The institution of Dr. Bjornevik has received research support from Michael J. Fox Foundation. The institution of Dr. Bjornevik has received research support from National Multiple Sclerosis Society. The institution of Dr. Bjornevik has received research support from Department of Defense.
Alberto Ascherio, MD, PhD Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .